Impressive Global Advancement Of India's CROs & CDMOs

By Rob Maddox, Chief Business Officer, LAXAI Life Sciences

India's CROs & CDMOs have witnessed remarkable growth in the global marketplace. Leading Indian pharmaceutical companies have also ventured into establishing their own CROs/CDMOs, further reinforcing the industry's strength. Beyond competitive pricing, Indian service providers offer remarkable scale, abundance of scientific talent, and cutting-edge facilities along with the capability to manage a wide breadth of projects.

Learn how leveraging Indian CDMOs’ rapid, innovative solutions and extensive expertise can enable cost-effective, efficient, and high-quality solutions to ensure your product maintains a competitive edge in the market.